NDE1_HUMAN - dbPTM
NDE1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NDE1_HUMAN
UniProt AC Q9NXR1
Protein Name Nuclear distribution protein nudE homolog 1
Gene Name NDE1
Organism Homo sapiens (Human).
Sequence Length 335
Subcellular Localization Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, spindle. Cleavage furrow. Localizes to the interphase and S phase centrosome. During mitosis, p
Protein Description Required for centrosome duplication and formation and function of the mitotic spindle. Essential for the development of the cerebral cortex. May regulate the production of neurons by controlling the orientation of the mitotic spindle during division of cortical neuronal progenitors of the proliferative ventricular zone of the brain. Orientation of the division plane perpendicular to the layers of the cortex gives rise to two proliferative neuronal progenitors whereas parallel orientation of the division plane yields one proliferative neuronal progenitor and a post-mitotic neuron. A premature shift towards a neuronal fate within the progenitor population may result in an overall reduction in the final number of neurons and an increase in the number of neurons in the deeper layers of the cortex..
Protein Sequence MEDSGKTFSSEEEEANYWKDLAMTYKQRAENTQEELREFQEGSREYEAELETQLQQIETRNRDLLSENNRLRMELETIKEKFEVQHSEGYRQISALEDDLAQTKAIKDQLQKYIRELEQANDDLERAKRATIMSLEDFEQRLNQAIERNAFLESELDEKENLLESVQRLKDEARDLRQELAVQQKQEKPRTPMPSSVEAERTDTAVQATGSVPSTPIAHRGPSSSLNTPGSFRRGLDDSTGGTPLTPAARISALNIVGDLLRKVGALESKLASCRNLVYDQSPNRTGGPASGRSSKNRDGGERRPSSTSVPLGDKGLDTSCRWLSKSTTRSSSSC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEDSGKTFSSE
----CCCCCCCCCCH
28.9628450419
7Phosphorylation-MEDSGKTFSSEEEE
-CCCCCCCCCCHHHH
32.0723663014
9PhosphorylationEDSGKTFSSEEEEAN
CCCCCCCCCHHHHHH
41.9125159151
10PhosphorylationDSGKTFSSEEEEANY
CCCCCCCCHHHHHHH
44.8525159151
131PhosphorylationLERAKRATIMSLEDF
HHHHHHHHHCCHHHH
22.6521677187
133SulfoxidationRAKRATIMSLEDFEQ
HHHHHHHCCHHHHHH
3.0421406390
154PhosphorylationERNAFLESELDEKEN
HHHHHHHHHHHHHHH
45.68-
165PhosphorylationEKENLLESVQRLKDE
HHHHHHHHHHHHHHH
24.4225159151
191PhosphorylationQKQEKPRTPMPSSVE
HHHCCCCCCCCCCCE
32.2529255136
193SulfoxidationQEKPRTPMPSSVEAE
HCCCCCCCCCCCEEC
5.0621406390
195PhosphorylationKPRTPMPSSVEAERT
CCCCCCCCCCEECCC
40.5420068231
196PhosphorylationPRTPMPSSVEAERTD
CCCCCCCCCEECCCC
20.3621815630
202PhosphorylationSSVEAERTDTAVQAT
CCCEECCCCCCCHHC
29.2525850435
204PhosphorylationVEAERTDTAVQATGS
CEECCCCCCCHHCCC
28.2825850435
209PhosphorylationTDTAVQATGSVPSTP
CCCCCHHCCCCCCCC
16.9530266825
211 (in isoform 2)Phosphorylation-26.8818220336
211PhosphorylationTAVQATGSVPSTPIA
CCCHHCCCCCCCCCC
26.8830266825
214PhosphorylationQATGSVPSTPIAHRG
HHCCCCCCCCCCCCC
44.6630266825
215 (in isoform 2)Phosphorylation-16.7918220336
215PhosphorylationATGSVPSTPIAHRGP
HCCCCCCCCCCCCCC
16.7925159151
223PhosphorylationPIAHRGPSSSLNTPG
CCCCCCCCCCCCCCC
35.0723403867
224PhosphorylationIAHRGPSSSLNTPGS
CCCCCCCCCCCCCCC
41.8125159151
225PhosphorylationAHRGPSSSLNTPGSF
CCCCCCCCCCCCCCC
29.9423403867
228PhosphorylationGPSSSLNTPGSFRRG
CCCCCCCCCCCCCCC
34.0325159151
228 (in isoform 2)Phosphorylation-34.0318220336
231PhosphorylationSSLNTPGSFRRGLDD
CCCCCCCCCCCCCCC
19.4523401153
239PhosphorylationFRRGLDDSTGGTPLT
CCCCCCCCCCCCCCC
28.7223401153
240PhosphorylationRRGLDDSTGGTPLTP
CCCCCCCCCCCCCCH
46.7730266825
243PhosphorylationLDDSTGGTPLTPAAR
CCCCCCCCCCCHHHH
19.2330266825
246PhosphorylationSTGGTPLTPAARISA
CCCCCCCCHHHHHHH
16.4630266825
252PhosphorylationLTPAARISALNIVGD
CCHHHHHHHHHHHHH
22.5828348404
270UbiquitinationKVGALESKLASCRNL
HHCHHHHHHHHHHHC
38.40-
273PhosphorylationALESKLASCRNLVYD
HHHHHHHHHHHCCCC
24.8526074081
274S-palmitoylationLESKLASCRNLVYDQ
HHHHHHHHHHCCCCC
2.5119927128
279PhosphorylationASCRNLVYDQSPNRT
HHHHHCCCCCCCCCC
16.0721945579
282PhosphorylationRNLVYDQSPNRTGGP
HHCCCCCCCCCCCCC
22.6519664994
286PhosphorylationYDQSPNRTGGPASGR
CCCCCCCCCCCCCCC
53.8022199227
291PhosphorylationNRTGGPASGRSSKNR
CCCCCCCCCCCCCCC
37.5630576142
294PhosphorylationGGPASGRSSKNRDGG
CCCCCCCCCCCCCCC
49.5421712546
306PhosphorylationDGGERRPSSTSVPLG
CCCCCCCCCCCCCCC
44.4229255136
306 (in isoform 2)Phosphorylation-44.4225849741
307PhosphorylationGGERRPSSTSVPLGD
CCCCCCCCCCCCCCC
27.6427273156
307 (in isoform 2)Phosphorylation-27.6425159151
308PhosphorylationGERRPSSTSVPLGDK
CCCCCCCCCCCCCCC
37.7730266825
308 (in isoform 2)Phosphorylation-37.7723927012
309PhosphorylationERRPSSTSVPLGDKG
CCCCCCCCCCCCCCC
24.5630266825
309 (in isoform 2)Phosphorylation-24.5625627689
320 (in isoform 2)Phosphorylation-37.3425159151
328PhosphorylationCRWLSKSTTRSSSSC
CHHHCCCCCCCCCCC
40.1120068231
329 (in isoform 2)Phosphorylation-26.3924719451
331PhosphorylationLSKSTTRSSSSC---
HCCCCCCCCCCC---
23.4127732954
332PhosphorylationSKSTTRSSSSC----
CCCCCCCCCCC----
28.5325159151
333PhosphorylationKSTTRSSSSC-----
CCCCCCCCCC-----
24.1320068231
337PhosphorylationRSSSSC---------
CCCCCC---------
40.6927732954

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
131TPhosphorylationKinasePRKACAP17612
GPS
191TPhosphorylationKinaseCDK1P06493
PSP
191TPhosphorylationKinaseCDK5Q00535
PSP
215TPhosphorylationKinaseCDK1P06493
PSP
228TPhosphorylationKinaseCDK1P06493
PSP
228TPhosphorylationKinaseCDK2P24941
PSP
243TPhosphorylationKinaseCDK1P06493
PSP
246TPhosphorylationKinaseCDK1P06493
PSP
282SPhosphorylationKinaseCDK1P06493
PSP
306SPhosphorylationKinasePRKACAP17612
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
246TPhosphorylation

16682949

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NDE1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LIS1_HUMANPAFAH1B1physical
10931877
NDEL1_HUMANNDEL1physical
24722188
ANDR_HUMANARphysical
24722188
ARNT2_HUMANARNT2physical
24722188
RIMB1_HUMANBZRAP1physical
24722188
NDE1_HUMANNDE1physical
24722188
FAM9B_HUMANFAM9Bphysical
24722188
GOGA2_HUMANGOLGA2physical
24722188
HXA2_HUMANHOXA2physical
24722188
LZTS2_HUMANLZTS2physical
24722188
MED4_HUMANMED4physical
24722188
MKRN3_HUMANMKRN3physical
24722188
NDC80_HUMANNDC80physical
24722188
REL_HUMANRELphysical
24722188
TFP11_HUMANTFIP11physical
24722188
TRI27_HUMANTRIM27physical
24722188
TTC1_HUMANTTC1physical
24722188
UBQL1_HUMANUBQLN1physical
24722188
USBP1_HUMANUSHBP1physical
24722188
WAC_HUMANWACphysical
24722188
ZN398_HUMANZNF398physical
24722188
DCA13_HUMANDCAF13physical
26496610
MTNB_HUMANAPIPphysical
26496610
AMZ2_HUMANAMZ2physical
26496610
CLP1L_HUMANCLPTM1Lphysical
26496610
LIS1_HUMANPAFAH1B1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614019Lissencephaly 4 (LIS4)
605013Microhydranencephaly (MHAC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NDE1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Palmitoylation
ReferencePubMed
"Ndel1 palmitoylation: a new mean to regulate cytoplasmic dyneinactivity.";
Shmueli A., Segal M., Sapir T., Tsutsumi R., Noritake J., Bar A.,Sapoznik S., Fukata Y., Orr I., Fukata M., Reiner O.;
EMBO J. 29:107-119(2010).
Cited for: PALMITOYLATION AT CYS-274 BY ZDHHC2; ZDHHC3 AND ZDHHC7.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; THR-215; THR-228;SER-231; SER-239; THR-240; THR-243; THR-246 AND SER-282, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; THR-215 ANDTHR-228, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-307, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-279, AND MASSSPECTROMETRY.

TOP